关键词: 多发性骨髓瘤, 人工智能, 延续护理, 随访系统

Abstract:

Objective To construct an artificial intelligence follow-up system for multiple myeloma patients based on patient needs，and to evaluate its application effect. Methods From March to May 2022，308 patients with multiple myeloma were selected from 3 tertiary hospitals in Shandong via convenience sampling method，and they were investigated by the cognition and demand content questionnaire of the artificial intelligence follow-up system，and the module of the follow-up system was developed，and its functions were combined with the initial application of the follow-up system for patients with hematologic diseases. From July to December 2022，patients’ symptom management level and satisfaction before and after application of the system were evaluated by the cancer patient self-management assessment scale and the continuous Care Smart platform using the questionnaire. The continuous Care Smart platform was used to evaluate the application satisfaction of medical staff with the questionnaire. Results The artificial intelligence follow-up system for multiple myeloma patients consisted of 2 modules and 9 functions. After the system was applied，the self-management level of 83 patients with multiple myeloma was higher than that before application（P<0.05）；the satisfaction score of patients was （67.36±8.27） points；the timely completion rate of follow-up was higher than that before the application （P<0.01）. The satisfaction of medical staff on the practicability，convenience，reliability and accuracy of the system was more than 95%，and the satisfaction of intelligence was 84.6%. Conclusion The artificial intelligence follow-up system for multiple myeloma patients has a scientific construction process，good practicability and convenience，and patients have high satisfaction with it.

Key words: Multiple Myeloma, Artificial Intelligence, Continuing Care, Follow-Up System